跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,194 条关于
“insulin efsitora alfa-gobe”
全部
12,194
临床试验
9,923
药物
850
机构
37
资讯
1,384
前天
FDA Approves Lilly's Onswik, a Once-Weekly Basal Insulin for Type 2 Diabetes
去年
Lilly's Once-Weekly Insulin Efsitora Alfa Achieves Non-Inferiority in Phase 3 Trials, Reducing Injection Burden by 300 Doses Annually
2年前
Eli Lilly's Efsitora Alfa Shows Promise in Type 2 Diabetes Treatment
2年前
Lilly's Once-Weekly Insulin Efsitora Shows Promise in Phase 3 Diabetes Trials
2年前
Eli Lilly's Once-Weekly Insulin Efsitora Demonstrates Non-Inferior Efficacy in Phase 3 Trials for Type 2 Diabetes
2年前
Eli Lilly's Weekly Insulin Efsitora Shows Promise in Phase 3 Trials
2年前
Eli Lilly's Efsitora Shows Promise in Phase III Trial, Challenging Novo Nordisk's Icodec
去年
Diabetes Pipeline Shows Robust Growth with 200+ Companies Developing Novel Therapies
去年
Type 1 Diabetes Pipeline Shows Robust Growth with 85+ Companies Developing 100+ Therapeutic Candidates
去年
Landmark Clinical Trials of 2024: Advancements in Cancer, Metabolic Diseases, and Infectious Diseases
第 1 页，共 139 页
上一页
下一页
